Maraviroc: a review of its use in HIV infection and beyond
Shawna M Woollard, Georgette D Kanmogne Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA Abstract: The human immunodeficiency virus-1 (HIV-1) enters target cells by binding its envelope glycoprotein gp120 to the CD4 receptor and/or cor...
Main Authors: | Woollard SM, Kanmogne GD |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/maraviroc-a-review-of-its-use-in-hiv-infection-and-beyond-peer-reviewed-article-DDDT |
Similar Items
-
Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
by: Gonzalez-Serna A, et al.
Published: (2016-01-01) -
Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.
by: Ai Kawana-Tachikawa, et al.
Published: (2014-01-01) -
Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients.
by: Nicholas Funderburg, et al.
Published: (2010-10-01) -
Lack of effect of Maraviroc intensification on blood and gut reservoir.
by: Tiraboschi, J, et al.
Published: (2016) -
Role of maraviroc and/or rapamycin in the liver of IL10 KO mice with frailty syndrome.
by: Laura Pérez-Martínez, et al.
Published: (2024-01-01)